Prognostic and predictive factors in patients with metastatic or recurrent cervical cancer treated with platinum-based chemotherapy.

Prognostic and predictive factors in patients with metastatic or recurrent cervical cancer treated with platinum-based chemotherapy.

Abstract Background Recognizing resistance or susceptibility to the current standard cisplatin and paclitaxel treatment could improve therapeutic outcomes of metastatic or recurrent cervical cancer. Methods Forty-five tissue samples from patients participating in a phase II trial of cisplatin and if...

Full description

Bibliographic Details
Main Authors:	Sofia Karageorgopoulou, Ioannis D. Kostakis, Maria Gazouli, Sonia Markaki, Marios Papadimitriou, Evangelos Bournakis, Meletios-Athanassios Dimopoulos, Christos A Papadimitriou
Format:	Article
Language:	English
Published:	BMC 2017-06-01
Series:	BMC Cancer
Online Access:	http://link.springer.com/article/10.1186/s12885-017-3435-x

Similar Items

Excision Repair Cross-Complementation Group 1 Enzyme as a Molecular Determinant of Responsiveness to Platinum-Based Chemotherapy for non Small-Cell Lung Cancer
by: Christos Papadimitriou, et al.
Published: (2008-01-01)

Novel Approaches for Concurrent Irradiation in Locally Advanced Cervical Cancer: Platinum Combinations, Non-Platinum-Containing Regimens, and Molecular Targeted Agents
by: Giannis Mountzios, et al.
Published: (2013-01-01)

Excision Repair Cross-Complementation Group 1 Enzyme as a Molecular Determinant of Responsiveness to Platinum-Based Chemotherapy for non Small-Cell Lung Cancer
by: Giannis Mountzios M.D., M.Sc., et al.
Published: (2008-01-01)

Nimotuzumab plus platinum-based chemotherapy platinum-based chemotherapy alone in patients with recurrent or metastatic nasopharyngeal carcinoma
by: Yunshu Zhu, et al.
Published: (2020-09-01)

Heat Shock Protein 90 (Hsp90) Expression and Breast Cancer
by: Christos A. Papadimitriou, et al.
Published: (2012-09-01)

Re-challenge of Platinum-based Chemotherapy for Platinum-refractory Patients with Recurrent or Metastatic Head and Neck Cancer: Claims Data Analysis in Japan
by: Makoto Tahara, et al.

Prognostic impact of tumor infiltrating lymphocytes on patients with metastatic urothelial carcinoma receiving platinum based chemotherapy
by: Hui-Shan Huang, et al.
Published: (2018-05-01)

Phase II study of gemcitabine plus S-1 chemotherapy in recurrent and metastatic nasopharyngeal carcinoma patients after failure of platinum-based chemotherapy
by: PeiJian Peng, et al.
Published: (2016-05-01)

Prognostic value of early radiological response to first‐line platinum‐containing chemotherapy in patients with metastatic nasopharyngeal carcinoma
by: Guo‐Ying Liu, et al.
Published: (2020-02-01)

Prognostic score in patients with recurrent or metastatic carcinoma of the head and neck treated with cetuximab and chemotherapy.
by: Teresa Magnes, et al.
Published: (2017-01-01)

Safety and efficacy of S-1 chemotherapy in recurrent and metastatic nasopharyngeal carcinoma patients after failure of platinum-based chemotherapy: multi-institutional retrospective analysis
by: Peng PJ, et al.
Published: (2014-08-01)

Gestational trophoblastic neoplasia with retroperitoneal metastases: A fatal complication
by: Dimopoulos Athanassios-Meletios, et al.
Published: (2010-12-01)

Cost-effectiveness of adding cetuximab to platinum-based chemotherapy for first-line treatment of recurrent or metastatic head and neck cancer.
by: Malek B Hannouf, et al.
Published: (2012-01-01)

From Nash Equilibria to Chain Recurrent Sets: An Algorithmic Solution Concept for Game Theory
by: Christos Papadimitriou, et al.
Published: (2018-10-01)

Chemotherapy for advanced or recurrent cervical cancer
by: Toshiharu Kamura, et al.
Published: (2013-06-01)

Metabolites as Prognostic Markers for Metastatic Non-Small Cell Lung Cancer (NSCLC) Patients Treated with First-Line Platinum-Doublet Chemotherapy
by: Desirée Hao, et al.
Published: (2020-07-01)

Treatment of early uterine sarcomas: disentangling adjuvant modalities
by: Kouloulias Vassilios, et al.
Published: (2009-04-01)

Prognostic Biomarkers of Salvage Chemotherapy Following Nivolumab Treatment for Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma
by: Takahiro Wakasaki, et al.
Published: (2020-08-01)

Principles of Monitoring Metastatic Disease and Chemotherapy Regimens for Recurrent or Metastatic Breast Cancer
by: NCCN Clinical Practice Guidelines in Oncology: Breast Cancer (Version 1.213)
Published: (2013-06-01)

Prognostic Significance of Gene Expression and DNA Methylation Markers in Circulating Tumor Cells and Paired Plasma Derived Exosomes in Metastatic Castration Resistant Prostate Cancer
by: Martha Zavridou, et al.
Published: (2021-02-01)

Multi-institutional prospective study of nedaplatin plus S-1 chemotherapy in recurrent and metastatic nasopharyngeal carcinoma patients after failure of platinum-containing regimens
by: Pei-Jian Peng, et al.
Published: (2017-02-01)

Identification of prognostic factors for cervical cancer recurrences
by: Liu, chih-chwen, et al.
Published: (1997)

Organ-Specific Therapeutic Effect of Paclitaxel and Carboplatin Chemotherapy After Platinum-Based Chemotherapy and Pembrolizumab for Metastatic Urothelial Carcinoma
by: Furubayashi N, et al.
Published: (2020-10-01)

Aberrant DNA damage response pathways may predict the outcome of platinum chemotherapy in ovarian cancer.
by: Dimitra T Stefanou, et al.
Published: (2015-01-01)

The Efficacy and Response Predictors of Platinum-Based Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer
by: Huang Y, et al.
Published: (2020-10-01)

A Prognostic Model in Metastatic or Recurrent Gastric Cancer Patients with Good Performance Status Who Received First-Line Chemotherapy
by: Jin Wang, et al.
Published: (2016-06-01)

Correction: Aberrant DNA Damage Response Pathways May Predict the Outcome of Platinum Chemotherapy in Ovarian Cancer
by: Dimitra T. Stefanou, et al.
Published: (2021-01-01)

Correction: Aberrant DNA Damage Response Pathways May Predict the Outcome of Platinum Chemotherapy in Ovarian Cancer.
by: Dimitra T Stefanou, et al.
Published: (2021-01-01)

Chemoradiation and the Role of Adjuvant Chemotherapy in Lymph Nodal–Metastatic Cervical Cancer
by: Nasir Ali, et al.
Published: (2017-06-01)

Theurapeutic Response of Neoadjuvant Chemotherapy between Platinum and Ifosfamide Combination and Platinum, Vincristine and Bleomycin Combination in Cervical Carcinoma Stage IB2
by: Kartiwa H Nuryanto, et al.
Published: (2016-01-01)

Repeating platinum/bevacizumab in recurrent or progressive cervical cancer yields marginal survival benefits
by: Abigail S. Zamorano, et al.
Published: (2017-11-01)

351 Pembrolizumab plus lenvatinib vs chemotherapy and lenvatinib monotherapy for recurrent/metastatic head and neck squamous cell carcinoma that progressed on platinum therapy and immunotherapy: LEAP-009
by: Makoto Tahara, et al.
Published: (2020-11-01)

miR-206 as a prognostic and sensitivity biomarker for platinum chemotherapy in epithelial ovarian cancer
by: Xiaotang Yu, et al.
Published: (2020-11-01)

Epidermal growth factor as a potential prognostic and predictive biomarker of response to platinum-based chemotherapy.
by: Margot Geens, et al.
Published: (2021-01-01)

Ex Vivo Models Simulating the Bone Marrow Environment and Predicting Response to Therapy in Multiple Myeloma
by: Konstantinos Papadimitriou, et al.
Published: (2020-07-01)

Supersymmetry anomalies in new minimal supergravity
by: Ioannis Papadimitriou
Published: (2019-09-01)

Supersymmetry anomalies in N = 1 $$ \mathcal{N}=1 $$ conformal supergravity
by: Ioannis Papadimitriou
Published: (2019-04-01)

Supercurrent anomalies in 4d SCFTs
by: Ioannis Papadimitriou
Published: (2017-07-01)

Phase equilibria studies in Nb-rich systems
by: Papadimitriou, Ioannis
Published: (2015)

Lactate dehydrogenase kinetics predict chemotherapy response in recurrent metastatic nasopharyngeal carcinoma
by: Luo Huang, et al.
Published: (2020-11-01)

Cannot write session to /tmp/vufind_sessions/sess_lqb8ohc53ci4kvsptfpgvd5vnd